| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-11 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.26 | 3e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.47 | 7e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |